Cargando…

Non-Traditional Pro-Inflammatory and Pro-Atherosclerotic Risk Factors Related to Systemic Lupus Erythematosus

Cardiovascular diseases (CVD) are one of the leading causes of high mortality in patients with systemic lupus erythematosus (SLE). The Framingham risk score and other traditional risk factors do not fully reflect the CVD risk in SLE patients. Therefore, in order to stratify these high-risk patients,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richter, Patricia, Cardoneanu, Anca, Rezus, Ciprian, Burlui, Alexandra Maria, Rezus, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604037/ https://www.ncbi.nlm.nih.gov/pubmed/36293458 http://dx.doi.org/10.3390/ijms232012604

Ejemplares similares

Interstitial Lung Disease in Systemic Lupus Erythematosus and Systemic Sclerosis: How Can We Manage the Challenge?
por: Richter, Patricia, et al.
Publicado: (2023)

Cytokines in Systemic Lupus Erythematosus—Focus on TNF-α and IL-17
por: Richter, Patricia, et al.
Publicado: (2023)

Why Do We Need JAK Inhibitors in Systemic Lupus Erythematosus?
por: Richter, Patricia, et al.
Publicado: (2022)

Ischemic Heart Disease and Rheumatoid Arthritis—Two Conditions, the Same Background
por: Rezuș, Elena, et al.
Publicado: (2021)

Characteristics of the intestinal microbiome in ankylosing spondylitis
por: Cardoneanu, Anca, et al.
Publicado: (2021)

Adult-Onset Still’s Disease—A Complex Disease, a Challenging Treatment
por: Macovei, Luana Andreea, et al.
Publicado: (2022)

From Pathogenesis to Therapy in Knee Osteoarthritis: Bench-to-Bedside
por: Rezuş, Elena, et al.
Publicado: (2021)

Multicentric Reticulohistiocytosis Exhibiting Positive HLA-B*07 and HLA-B*08: A Case Report
por: Rezuș, Elena, et al.
Publicado: (2020)

A patient-centered approach to the burden of symptoms in patients with scleroderma treated with Bosentan: A prospective single-center observational study
por: Rezus, Elena, et al.
Publicado: (2020)

Diet in Scleroderma: Is There a Need for Intervention?
por: Burlui, Alexandra Maria, et al.
Publicado: (2021)

Inactivity and Skeletal Muscle Metabolism: A Vicious Cycle in Old Age
por: Rezuş, Elena, et al.
Publicado: (2020)

Targeting Systemic Sclerosis from Pathogenic Mechanisms to Clinical Manifestations: Why IL-6?
por: Cardoneanu, Anca, et al.
Publicado: (2022)

The Involvement of Smooth Muscle, Striated Muscle, and the Myocardium in Scleroderma: A Review
por: Bratoiu, Ioana, et al.
Publicado: (2022)

The Link Between Inflammaging and Degenerative Joint Diseases
por: Rezuș, Elena, et al.
Publicado: (2019)

Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review
por: Mihai, Ioana Ruxandra, et al.
Publicado: (2023)

Temporomandibular Joint Osteoarthritis: Pathogenic Mechanisms Involving the Cartilage and Subchondral Bone, and Potential Therapeutic Strategies for Joint Regeneration
por: Cardoneanu, Anca, et al.
Publicado: (2022)

Adult-onset Still's disease and the role of dermatological manifestations: A case report and literature review
por: Vâță, Andrei, et al.
Publicado: (2021)

Predictors Associated with Adverse Pregnancy Outcomes in a Cohort of Women with Systematic Lupus Erythematosus from Romania—An Observational Study (Stage 2)
por: Vicoveanu, Petronela, et al.
Publicado: (2022)

Idazoxan and Efaroxan Potentiate the Endurance Performances and the Antioxidant Activity of Ephedrine in Rats
por: Rusu-Zota, Gabriela, et al.
Publicado: (2021)

The pro-inflammatory potential of T cells in juvenile-onset systemic lupus erythematosus
por: Ballantine, Lucy E, et al.
Publicado: (2014)

The role of endocan and selected pro-inflammatory cytokines in systemic lupus erythematosus
por: Tokarska, Kamila, et al.
Publicado: (2019)

Association study of genetic variants of pro-inflammatory chemokine and cytokine genes in systemic lupus erythematosus
por: Sánchez, Elena, et al.
Publicado: (2006)

Elevated Expression and Pro-Inflammatory Activity of IL-36 in Patients with Systemic Lupus Erythematosus
por: Chu, Man, et al.
Publicado: (2015)

QT interval variations and mortality risk: Is there any relationship?
por: Rezuş, Ciprian, et al.
Publicado: (2015)

Osteonecrosis of the Femoral Head in Patients with Hypercoagulability—From Pathophysiology to Therapeutic Implications
por: Rezus, Elena, et al.
Publicado: (2021)

MicroRNAs (miRNAs) in Cardiovascular Complications of Rheumatoid Arthritis (RA): What Is New?
por: Tanase, Daniela Maria, et al.
Publicado: (2022)

Crosstalk between miR-146a and pro-inflammatory cytokines in patients with systemic lupus erythematosus
por: El-Akhras, Basima A, et al.
Publicado: (2023)

Beyond the Cardiorenal Syndrome: Pathophysiological Approaches and Biomarkers for Renal and Cardiac Crosstalk
por: Buliga-Finis, Oana Nicoleta, et al.
Publicado: (2022)

Cardiovascular Risk Assessment in Rheumatoid Arthritis: Accelerated Atherosclerosis, New Biomarkers, and the Effects of Biological Therapy
por: Popescu, Diana, et al.
Publicado: (2023)

Current Knowledge of MicroRNAs (miRNAs) in Acute Coronary Syndrome (ACS): ST-Elevation Myocardial Infarction (STEMI)
por: Tanase, Daniela Maria, et al.
Publicado: (2021)

An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques
por: Fredman, Gabrielle, et al.
Publicado: (2016)

Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis—From Pathophysiology to Therapeutic Implications
por: Badescu, Minerva Codruta, et al.
Publicado: (2022)

Managing Anemia: Point of Convergence for Heart Failure and Chronic Kidney Disease?
por: Buliga-Finis, Oana Nicoleta, et al.
Publicado: (2023)

Endosome Traffic Modulates Pro-Inflammatory Signal Transduction in CD4(+) T Cells—Implications for the Pathogenesis of Systemic Lupus Erythematosus
por: Park, Joy S., et al.
Publicado: (2023)

Intracerebroventricular Coadministration of Protoxin-II and Trace Elements in Rats Enhances the Analgesic Effect of the 1.7 Voltage-Gate Sodium Channel Blocker
por: Stanciu, Gabriela-Dumitrita, et al.
Publicado: (2019)

Myocardial Ischemia Related to Common Cancer Therapy—Prevention Insights
por: Badescu, Minerva Codruta, et al.
Publicado: (2022)

The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases
por: Tudorancea, Ivona Maria, et al.
Publicado: (2022)

From Pathogenesis to Treatment—New Perspectives in Rheumatology
por: Rezus, Elena, et al.
Publicado: (2023)

Cardiovascular Disease in Systemic Lupus Erythematosus: The Role of Traditional and Lupus Related Risk Factors
por: Zeller, Carlos Borelli, et al.
Publicado: (2008)

Impact of inflammation-mediated response on pan-coronary plaque vulnerability, myocardial viability and ventricular remodeling in the postinfarction period - the VIABILITY study: Protocol for a non-randomized prospective clinical study
por: Morariu, Mirabela, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_adrisjphckjcbj76r8oje4c07q